Eroglu Z, Kim Y, Gibney G, et al. Mature results of combination nivolumab (NIVO) plus ipilimumab (IPI) as adjuvant therapy in stage IIIC/IV melanoma (MEL). SMR 2017, abstract SMR09-06.
FIT nuttig voor triage darmkanker in de eerste lijn
jun 2021 | Maag-darm-leveroncologie